Zonisamide clinical trials
Also written Zonegran.
How each study uses Zonisamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Zonisamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 27 Mar 2000 · ZONEGRAN · NDA 020789 (FDA, Drugs@FDA)
- European Union
- 10 Mar 2005 · Zonegran · EMEA/H/C/000577 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
64 studies that test it; most in 2008 (11)
| Year | Studies |
|---|---|
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 8 |
| 2006 | 7 |
| 2007 | 2 |
| 2008 | 11 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 30 · Other 34
Eisai Inc. (7) · Eisai Limited (5) · Eisai Korea Inc. (3) · Washington University School of Medicine (3) · Kafrelsheikh University (2) · Rose Research Center, LLC (2) · Mylan Pharmaceuticals Inc (2) · Yale University (2)
Often tested with
Tested in the same studies.
Topiramate (4) · Carbamazepine (4) · Levetiracetam (4) · Lamotrigine (4) · Valproic Acid (3) · Bupropion (2) · Oxcarbazepine (2) · Propranolol (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Zonisamide.
- Aug 2027The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) StudyPhase 2 · Washington State University
- Sep 2027Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset SeizuresPhase 4 · Azurity Pharmaceuticals
Studies
Open first, then newest update. How each study uses Zonisamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 64
- Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset SeizuresNot yet recruitingPhase 4Azurity PharmaceuticalsNCT06534502Written as Zonisamide Oral Product
- Zonisamide Versus Propranolol in MigraineRecruitingPhase 3Kafrelsheikh UniversityNCT06361446Written as Zonisamide 50 MG
- Modification of Epilepsy Screen Questionnaire and Treatment Feasibility EvaluationNot yet recruitingNot applicableNational Taiwan University HospitalNCT04939675Written as Zonisamide 100mg
- The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) StudyActive, not recruitingPhase 2Washington State UniversityNCT05134857Written as Zonisamide
- Zonisamide Versus Topiramate in MigraineCompletedPhase 3Kafrelsheikh UniversityNCT06347497Written as Zonisamide 50 MG
- Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)TerminatedPhase 2Washington University School of MedicineNCT04774250Written as Zonisamide 100Mg Cap
- The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic CigaretteCompletedPhase 3Rose Research Center, LLCNCT05205811Written as Zonisamide
- Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)CompletedPhase 4Mario Negri Institute for Pharmacological ResearchNCT03689114Written as Low dose zonisamide
- Noise-Induced Hearing Loss-Acute Exposure TreatmentTerminatedPhase 2Washington University School of MedicineNCT04768569Written as Zonisamide 100Mg Cap
- Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649714Written as Zonisamide Capsules 100 mg
- Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00650052Written as Zonisamide Capsules 100 mg
- Interdisciplinary Study of A Novel Anticonvulsant in AlcoholismCompletedPhase 3Boston University Charles River CampusNCT02901041Written as Zonisamide
- Role of Zonisamide in Advanced Parkinson's Disease (PD) in Egyptian Population: Pilot StudyCompletedNot applicableAin Shams UniversityNCT04182399Written as Zonisamide Capsules
- Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of ActionCompletedPhase 3Virginia Commonwealth UniversityNCT02900352Written as Zonisamide
- Study of Zonisamide in Early Parkinson DiseaseWithdrawnPhase 2/3Mazandaran University of Medical SciencesNCT01766128Written as Zonisamide
- Zonisamide/Bupropion Effects on Switching to Electronic CigarettesCompletedPhase 3Rose Research Center, LLCNCT04388319Written as Zonisamide
- Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial EpilepsyCompletedPhase 4Eisai Korea Inc.NCT01140867Written as zonisamide
- Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety EvaluationCompletedPhase 4Eisai Korea Inc.NCT01127256Written as zonisamide
- An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's DiseaseSuspendedPhase 4The Cooper Health SystemNCT03034538Written as Zonegran
- Zonisamide Outpatient StudyWithdrawnPhase 2Pharmacotherapies for Alcohol and Substance Use Disorders AllianceNCT03376139Written as Zonisamide
See all 64 studies that test Zonisamide →
Given beside what is tested · 1 — Zonisamide is usual care or a partner of the new treatment
Codes
What other systems call Zonisamide · ClinicalTrials.gg INT006825
- MeSH (NLM) D000078305ZonisamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 459384H98VZONISAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 39998Confirmed FDA, Wikidata
- Wikidata Q219957zonisamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47790ZonisamideOne source FDA
- DrugBank DB00909One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078305 | Zonisamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 459384H98V | ZONISAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 39998 | — | Confirmed FDA, Wikidata |
| Wikidata | Q219957 | zonisamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47790 | Zonisamide | One source FDA |
| DrugBank | DB00909 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.